About
Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing novel small molecule therapeutics to treat drug-resistant and life-threatening fungal infections by targeting fungal stress response pathways to prevent and overcome antifungal resistance.
Explore Bright Angel Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.